Literature DB >> 34076350

The GSDMB rs7216389 SNP is associated with chronic rhinosinusitis in a multi-institutional cohort.

Dana E Zack1, Debra A Stern2, Amanda L Willis1, Alexander S Kim1, Corinne J Mansfield3, Danielle R Reed4, Steven G Brooks3, Nithin D Adappa3, James N Palmer3, Noam A Cohen3,4, Alexander G Chiu5, Brian H Song1, Chris H Le1, Eugene H Chang1.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is a multifactorial disease with a high co-occurrence with asthma. In this multicohort study, we tested whether single nucleotide polymorphisms (SNPs) associated with childhood asthma and rhinovirus (RV)-associated disease are related to an increased susceptibility to adult CRS in a multicohort retrospective case-control study.
METHODS: Participants at two tertiary academic rhinology centers, University of Arizona (UofA) and University of Pennsylvania (UPenn) were recruited. Cases were defined as those with physician diagnosed CRS (UofA, n = 149; UPenn, n = 250), and healthy controls were those without CRS (UofA, n = 66; UPenn, n = 275). Genomic DNA was screened for the GSDMB rs7216389 SNP and CDHR3 rs6967330 SNP. Gene dosage, or the number of combined risk alleles in a single subject was calculated. Meta-analysis of the association between GSDMB or CDHR3 genotypes and CRS was performed and additive gene dosage effect for each population calculated using p for trend.
RESULTS: A meta-analysis revealed a combined increased risk for CRS in subjects with the GSDMB rs7216389 SNP (odds ratio [OR] 1.40; 95% confidence interval [CI], 1.16-1.76; p = 0.004). Both the UofA (OR 1.73; 95% CI, 1.23-2.43; p = 0.002) and UPenn (OR 1.27; 95% CI, 1.02-1.58; p = 0.035) populations showed a significant positive association between the number of combined risk alleles of GSDMB rs7216389 SNP and CDHR3 rs6967330 SNP and risk for CRS.
CONCLUSION: Carriers of the GSDMB rs7216389 SNP and CDHR3 rs6967330 SNP are at increased susceptibility for CRS. These data suggest that therapeutic approaches to target aberrant responses to RV infection may play a role in the treatment of unified airway disease.
© 2021 ARS-AAOA, LLC.

Entities:  

Keywords:  asthma; chronic rhinosinusitis; genetics; hereditary; rhinovirus

Mesh:

Substances:

Year:  2021        PMID: 34076350      PMCID: PMC8636513          DOI: 10.1002/alr.22824

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  33 in total

Review 1.  Comorbidities of asthma and the unified airway.

Authors:  Robert J Stachler
Journal:  Int Forum Allergy Rhinol       Date:  2015-09       Impact factor: 3.858

Review 2.  Staging for rhinosinusitis.

Authors:  V J Lund; D W Kennedy
Journal:  Otolaryngol Head Neck Surg       Date:  1997-09       Impact factor: 5.591

Review 3.  Rhinosinusitis and asthma: the missing link.

Authors:  Anne E Dixon
Journal:  Curr Opin Pulm Med       Date:  2009-01       Impact factor: 3.155

4.  Rhinovirus wheezing illness and genetic risk of childhood-onset asthma.

Authors:  Minal Calışkan; Yury A Bochkov; Eskil Kreiner-Møller; Klaus Bønnelykke; Michelle M Stein; Gaixin Du; Hans Bisgaard; Daniel J Jackson; James E Gern; Robert F Lemanske; Dan L Nicolae; Carole Ober
Journal:  N Engl J Med       Date:  2013-03-27       Impact factor: 91.245

5.  Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.

Authors:  Peter Tomassen; Griet Vandeplas; Thibaut Van Zele; Lars-Olaf Cardell; Julia Arebro; Heidi Olze; Ulrike Förster-Ruhrmann; Marek L Kowalski; Agnieszka Olszewska-Ziąber; Gabriele Holtappels; Natalie De Ruyck; Xiangdong Wang; Cornelis Van Drunen; Joaquim Mullol; Peter Hellings; Valerie Hox; Elina Toskala; Glenis Scadding; Valerie Lund; Luo Zhang; Wytske Fokkens; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2016-03-04       Impact factor: 10.793

Review 6.  From endoplasmic-reticulum stress to the inflammatory response.

Authors:  Kezhong Zhang; Randal J Kaufman
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

Review 7.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

8.  A large-scale, consortium-based genomewide association study of asthma.

Authors:  Miriam F Moffatt; Ivo G Gut; Florence Demenais; David P Strachan; Emmanuelle Bouzigon; Simon Heath; Erika von Mutius; Martin Farrall; Mark Lathrop; William O C M Cookson
Journal:  N Engl J Med       Date:  2010-09-23       Impact factor: 91.245

9.  A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations.

Authors:  Klaus Bønnelykke; Patrick Sleiman; Kasper Nielsen; Eskil Kreiner-Møller; Josep M Mercader; Danielle Belgrave; Herman T den Dekker; Anders Husby; Astrid Sevelsted; Grissel Faura-Tellez; Li Juel Mortensen; Lavinia Paternoster; Richard Flaaten; Anne Mølgaard; David E Smart; Philip F Thomsen; Morten A Rasmussen; Silvia Bonàs-Guarch; Claus Holst; Ellen A Nohr; Rachita Yadav; Michael E March; Thomas Blicher; Peter M Lackie; Vincent W V Jaddoe; Angela Simpson; John W Holloway; Liesbeth Duijts; Adnan Custovic; Donna E Davies; David Torrents; Ramneek Gupta; Mads V Hollegaard; David M Hougaard; Hakon Hakonarson; Hans Bisgaard
Journal:  Nat Genet       Date:  2013-11-17       Impact factor: 38.330

10.  RV-C infections result in greater clinical symptoms and epithelial responses compared to RV-A infections in patients with CRS.

Authors:  Amanda L Willis; Joshua B Calton; Jaeden Calton; Alexander S Kim; Ray Lee; Elmira Torabzadeh; Dean D Billheimer; Christopher H Le; Fernando D Martinez; Eugene H Chang
Journal:  Allergy       Date:  2020-06-24       Impact factor: 14.710

View more
  1 in total

1.  CYSLTR1 rs320995 (T927C) and GSDMB rs7216389 (G1199A) Gene Polymorphisms in Asthma and Allergic Rhinitis: A Proof-of-Concept Study.

Authors:  Zhengshuo Jin; Zhouxian Pan; Ziran Wang; Lingjun Kong; Min Zhong; Yongshi Yang; Yaling Dou; Jin-Lyu Sun
Journal:  J Asthma Allergy       Date:  2022-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.